Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients

Filip Ionescu, MD, Girish B Nair, MD MS, FACP, Ioana Petrescu, MD, Anish S Konde, MD, Markie Sue Zimmer, MD, Nwabundo Anusim, MBBS, Vishal Jindal, MD, Susanna Gaikazian, MD, Joseph Anderson, MD, Michael Stender, MD, Marianne Terese Huben, DO, Ishmael Jaiyesimi, DO, MS

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-134835

Published: 2020

Journal Articles

Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis

Daniel E Ezekwudo, MD, Susanna Gaikazian, MD, Nwabundo Anusim, MD MPH, Anish S Konde, MD, Dana Zakalik, MD, Marianne Terese Huben, DO, Michael Stender, MD, Joseph Anderson, MD, Ishmael Jaiyesimi, DO, MS

Blood (2018) 132 (Supplement 1): 1244.

https://doi.org/10.1182/blood-2018-99-116197

Published: 2018

Journal Articles

Vascular Access Device Complications during Induction Chemotherapy for AML: A Single Institutional Analysis

David Macari, MD, Bolanle Gbadamosi, MD, Daniel E Ezekwudo, MD, Joseph Anderson, MD, Ishmael Jaiyesimi, DO, MS, Michael Stender, MD

Blood (2018) 132 (Supplement 1): 3529.

https://doi.org/10.1182/blood-2018-99-116980

Published: 2018

Journal Articles

Does Normal Reticulocyte Hemoglobin Rule out Iron Deficiency As a Cause of Normocytic Normochromic Anemia?

Zhou Yu, MD PhD, Leann Michelle Blankenship, MD, Mohammed Ibrahim, MD, Bolanle Gbadamosi, MD, Michael Stender, MD, Joseph Anderson, MD, Ishmael Jaiyesimi, DO, James Huang, MD

Blood (2016) 128 (22): 4826.

https://doi.org/10.1182/blood.V128.22.4826.4826

Published: 2016

Journal Articles

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Foluso Nelson Ogunleye, MD, Mohammed Ibrahim, MD, Leann Michelle Blankenship, MD, Siddhartha Yadav, MD, Tolulope Ifabiyi, Vonda Douglas, MD, Mark Micale, PhD, Elisa Quiroz, MD, Susanna S Gaikazian, MD, Michael Stender, MD, Marianne Terese Huben, DO, Joseph Anderson, MD, Ishmael Jaiyesimi, DO

Blood (2016) 128 (22): 5580.

https://doi.org/10.1182/blood.V128.22.5580.5580

Published: 2016

Journal Articles

Efficacy and Safety of Denileukin Diftitox (Ontak®) in the Treatment of Cutaneous T-Cell Lymphoma (CTCL) According to CD25 Status.

Francine Foss, MD, Madeleine Duvic, MD, Larisa Geskin, MD, Joseph Anderson, MD, Pierluigi Porcu, MD, Raymond J. Hohl, MD,PhD, Maureen Cooper, MD, Jasmine M. Zain, MD, John Zic, MD, Patrica Hibberd, MD,PhD, Mark Acosta, PharmD

Blood (2006) 108 (11): 2712.

https://doi.org/10.1182/blood.V108.11.2712.2712

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients

Clinical Outcome Following Reinstitution of Anticoagulation after Major Gastrointestinal Bleed: A Single Institutional Analysis

Vascular Access Device Complications during Induction Chemotherapy for AML: A Single Institutional Analysis

Does Normal Reticulocyte Hemoglobin Rule out Iron Deficiency As a Cause of Normocytic Normochromic Anemia?

Analysis of Genomic Aberrations and Its Impact on Survival in Patients with Chronic Lymphocytic Leukemia (CLL) at the William Beaumont Hospital Cancer Center

Efficacy and Safety of Denileukin Diftitox (Ontak®) in the Treatment of Cutaneous T-Cell Lymphoma (CTCL) According to CD25 Status.

Email alerts

ASH Publications

American Society of Hematology